Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating activities:
Net earnings	$ 367	$ 619
Adjustments to reconcile net earnings to net cash provided by operations:
Depreciation and amortization	167	157
Stock-based compensation	44	52
Deferred income taxes	11	(21)
Goodwill, trademark and other asset impairments	0	329
Other	7	(53)
Changes in:
Receivables, net	(56)	46
Inventories, net	(53)	(220)
Prepaid expenses and other current assets	2	(29)
Accounts payable and accrued liabilities	(93)	94
Operating lease right-of-use assets and liabilities, net	0	(1)
Income taxes payable / prepaid	55	(80)
Net cash provided by operations	451	893
Investing activities:
Capital expenditures	(172)	(232)
Businesses acquired, net of cash acquired	0	(85)
Other	5	(24)
Net cash used for investing activities	(167)	(341)
Financing activities:
Notes and loans payable, net	395	0
Long-term debt repayments	(300)	0
Treasury stock purchased	(25)	(605)
Cash dividends paid to Clorox stockholders	(428)	(420)
Cash dividends paid to noncontrolling interests	(5)	(18)
Issuance of common stock for employee stock plans and other	0	99
Net cash used for financing activities	(363)	(944)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(2)	10
Net increase (decrease) in cash, cash equivalents, and restricted cash	(81)	(382)
Cash, cash equivalents, and restricted cash:
Beginning of period	324	879
End of period	$ 243	$ 497